• $559.00
    Market Cap
  • -99.00%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
0
-100.00%
50,000
0.00%
50,000
0.00%
50,000
N/A
Cost of Revenue
N/A
N/A
729,000
-1.09%
737,000
+1.66%
725,000
N/A
Gross Profit
0
+100.00%
-679,000
-1.16%
-687,000
+1.78%
-675,000
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-10,000
-9.09%
-11,000
+10.00%
-10,000
-9.09%
-11,000
N/A
Depreciation and Amortization Expense
1,000
-66.67%
3,000
+50.00%
2,000
0.00%
2,000
N/A
Total Operating Expenses
703,000
-51.42%
1.4M
-1.16%
1.5M
+1.74%
1.4M
N/A
Operating Profit
-703,000
+3.53%
-679,000
-1.16%
-687,000
+1.78%
-675,000
N/A
Interest Income
-477,000
-76.50%
-2.0M
N/A
N/A
N/A
N/A
N/A
Interest Expense
0
+100.00%
-21,000
-19.23%
-26,000
+4.00%
-25,000
N/A
Interest Income and Expense and Net
-477,000
-76.74%
-2.1M
+7,788.46%
-26,000
+4.00%
-25,000
N/A
Total Nonoperating Income and Expense
-462,000
-77.47%
-2.1M
-30.52%
-3.0M
-159.17%
5.0M
N/A
Income before Taxes
-703,000
+3.53%
-679,000
-1.16%
-687,000
+1.78%
-675,000
N/A
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-1.2M
-57.33%
-2.7M
-24.98%
-3.6M
-184.35%
4.3M
N/A
Net Income from Continuing Operations Applicable to Common
-1.2M
-57.33%
-2.7M
-24.98%
-3.6M
-184.35%
4.3M
N/A
Basic EPS and Net Income
0.00
N/A
0.00
+100.00%
-0.01
-200.00%
0.01
N/A
Diluted EPS and Net Income
0.00
N/A
0.00
+100.00%
-0.01
-200.00%
0.01
N/A
Basic Weighted Average Shares
559.3M
0.00%
559.3M
0.00%
559.3M
+0.17%
558.3M
N/A
Diluted Weighted Average Shares
559.3M
0.00%
559.3M
0.00%
559.3M
-5.69%
593.1M
N/A
Balance Sheet
Cash and Cash Equivalents
67,000
-61.71%
175,000
-24.57%
232,000
-34.28%
353,000
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
67,000
-61.71%
175,000
-24.57%
232,000
-34.28%
353,000
N/A
Total Current Assets
69,000
-63.49%
189,000
-65.45%
547,000
-17.74%
665,000
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
0
-100.00%
1,000
-75.00%
4,000
-33.33%
6,000
N/A
Total Long-Term Assets
2,000
0.00%
2,000
0.00%
2,000
0.00%
2,000
N/A
Total Assets
316,000
-69.35%
1.0M
-70.15%
3.5M
-49.56%
6.8M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
60,000
-45.45%
110,000
-26.67%
150,000
0.00%
150,000
N/A
Total Current Liabilities
2.1M
+26.98%
1.7M
+22.56%
1.4M
+34.49%
1.0M
N/A
Total Long-Term Debt
N/A
N/A
250,000
+92.31%
130,000
+25.00%
104,000
N/A
Total Long-Term Liabilities
N/A
N/A
140,000
N/A
0
-100.00%
104,000
N/A
Total Liabilities
2.1M
+26.98%
1.7M
+22.56%
1.4M
+21.95%
1.1M
N/A
Retained Earnings
-72.4M
+1.64%
-71.3M
+3.98%
-68.5M
+5.61%
-64.9M
N/A
Total Stockholders Equity
-2.9M
+68.73%
-1.7M
-263.77%
1.0M
-77.86%
4.7M
N/A
Total Shares Outstanding
559.3M
0.00%
559.3M
0.00%
559.3M
0.00%
559.3M
N/A
Cash Flow
Cash from Operating Activities
-190,000
-45.56%
-349,000
-17.10%
-421,000
+8.51%
-388,000
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
0
N/A
N/A
N/A
Cash from Investing Activities
102,000
-69.28%
332,000
+10.67%
300,000
-37.50%
480,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-20,000
-50.00%
-40,000
N/A
0
N/A
0
N/A
Financials Ratio
Gross Margin
N/A
N/A
-1,358.00%
-1.16%
-1,374.00%
+1.78%
-1,350.00%
N/A
Operating Margin
N/A
N/A
-1,358.00%
-1.16%
-1,374.00%
+1.78%
-1,350.00%
N/A
Return on Assets
-172.98%
+42.09%
-121.74%
+72.32%
-70.65%
-174.29%
95.10%
N/A
Return on Equity
51.15%
-93.82%
827.27%
+748.93%
-127.48%
-154.21%
235.16%
N/A
Revenue Growth
-100.00%
N/A
0.00%
N/A
0.00%
+100.00%
-48.45%
N/A
Current Ratio
0.03
-71.23%
0.11
-71.81%
0.40
-38.84%
0.66
N/A
Cash Ratio
0.03
-69.88%
0.10
-38.48%
0.17
-51.12%
0.35
N/A
Debt-to-Equity Ratio
N/A
N/A
-0.21
-178.52%
0.27
+398.16%
0.05
N/A
Debt-to-Assets Ratio
N/A
N/A
0.35
+330.58%
0.08
+118.60%
0.04
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow